Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd … Read more
Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.082x
Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a cash flow conversion efficiency ratio of -0.082x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-4.35 Million) by net assets (ILA53.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tikun Olam Cannbit Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SPORE TECH ENG
MU:SJX
|
0.063x |
|
HONDA MOTOR (HDM.SG)
STU:HDM
|
0.012x |
|
TOTALLY PLC LS -10
F:UKXA
|
N/A |
|
JSW (J2S.SG)
STU:J2S
|
-0.008x |
|
HGM
VN:HGM
|
N/A |
|
TOYOBO
DU:TO7
|
N/A |
|
PRS Reit PLC
LSE:PRSR
|
0.016x |
|
FOCUS SYSTEMS
MU:FSM
|
N/A |
Annual Cash Flow Conversion Efficiency for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA-5.35 Million | ILA-3.77 Million | 0.705x | +870.69% |
| 2023-12-31 | ILA33.04 Million | ILA-3.02 Million | -0.092x | +41.26% |
| 2022-12-31 | ILA116.92 Million | ILA-18.22 Million | -0.156x | +3.30% |
| 2021-12-31 | ILA143.82 Million | ILA-23.17 Million | -0.161x | +10.07% |
| 2020-12-31 | ILA136.06 Million | ILA-24.38 Million | -0.179x | -433.18% |
| 2019-12-31 | ILA99.87 Million | ILA-3.36 Million | -0.034x | +99.79% |
| 2018-12-31 | ILA108.00K | ILA-1.76 Million | -16.278x | -7635.02% |
| 2017-12-31 | ILA-492.00K | ILA-106.29K | 0.216x | -- |